Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Investigation of the prevalence of antibodies against neurotropic polyomaviruses BK, JC and SV40 in sera from patients affected by multiple sclerosis.

Ribeiro T, Fleury MJ, Granieri E, Castellazzi M, Martini F, Mazzoni E, Coursaget P, Tognon M.

Neurol Sci. 2010 Aug;31(4):517-21. doi: 10.1007/s10072-010-0353-y. Epub 2010 Jun 15.

PMID:
20552238
2.

Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays.

Viscidi RP, Rollison DE, Viscidi E, Clayman B, Rubalcaba E, Daniel R, Major EO, Shah KV.

Clin Diagn Lab Immunol. 2003 Mar;10(2):278-85.

3.

Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40.

Knowles WA, Pipkin P, Andrews N, Vyse A, Minor P, Brown DW, Miller E.

J Med Virol. 2003 Sep;71(1):115-23.

PMID:
12858417
4.

Serum antibodies to JC virus, BK virus, simian virus 40, and the risk of incident adult astrocytic brain tumors.

Rollison DE, Helzlsouer KJ, Alberg AJ, Hoffman S, Hou J, Daniel R, Shah KV, Major EO.

Cancer Epidemiol Biomarkers Prev. 2003 May;12(5):460-3.

5.

Significant low prevalence of antibodies reacting with simian virus 40 mimotopes in serum samples from patients affected by inflammatory neurologic diseases, including multiple sclerosis.

Mazzoni E, Pietrobon S, Masini I, Rotondo JC, Gentile M, Fainardi E, Casetta I, Castellazzi M, Granieri E, Caniati ML, Tola MR, Guerra G, Martini F, Tognon M.

PLoS One. 2014 Nov 3;9(11):e110923. doi: 10.1371/journal.pone.0110923. eCollection 2014.

6.

An assay to quantify species-specific anti-JC virus antibody levels in MS patients.

Warnke C, Pawlita M, Dehmel T, Posevitz-Fejfar A, Hartung HP, Wiendl H, Kieseier BC, Adams O.

Mult Scler. 2013 Aug;19(9):1137-44. doi: 10.1177/1352458513475489. Epub 2013 Feb 6.

PMID:
23388163
7.

Lack of serologic evidence for prevalent simian virus 40 infection in humans.

Carter JJ, Madeleine MM, Wipf GC, Garcea RL, Pipkin PA, Minor PD, Galloway DA.

J Natl Cancer Inst. 2003 Oct 15;95(20):1522-30.

PMID:
14559874
8.

Seroprevalence rates of BKV, JCV, and MCPyV polyomaviruses in the general Czech Republic population.

Sroller V, Hamšíková E, Ludvíková V, Vochozková P, Kojzarová M, Fraiberk M, Saláková M, Morávková A, Forstová J, Němečková S.

J Med Virol. 2014 Sep;86(9):1560-8. doi: 10.1002/jmv.23841. Epub 2013 Nov 8.

PMID:
24214630
9.

Antibodies to JC and BK viruses among persons with non-Hodgkin lymphoma.

Engels EA, Rollison DE, Hartge P, Baris D, Cerhan JR, Severson RK, Cozen W, Davis S, Biggar RJ, Goedert JJ, Viscidi RP.

Int J Cancer. 2005 Dec 20;117(6):1013-9.

10.

T-cell responses to peptide fragments of the BK virus T antigen: implications for cross-reactivity of immune response to JC virus.

Li J, Melenhorst J, Hensel N, Rezvani K, Sconocchia G, Kilical Y, Hou J, Curfman B, Major E, Barrett AJ.

J Gen Virol. 2006 Oct;87(Pt 10):2951-60.

PMID:
16963754
11.

Longitudinal study of seroprevalence and serostability of the human polyomaviruses JCV and BKV in organ transplant recipients.

Antonsson A, Pawlita M, Feltkamp MC, Bouwes Bavinck JN, Euvrard S, Harwood CA, Naldi L, Nindl I, Proby CM, Neale RE, Waterboer T.

J Med Virol. 2013 Feb;85(2):327-35. doi: 10.1002/jmv.23472. Epub 2012 Nov 21.

PMID:
23172042
12.

Prevalence and stability of antibodies to the BK and JC polyomaviruses: a long-term longitudinal study of Australians.

Antonsson A, Green AC, Mallitt KA, O'Rourke PK, Pawlita M, Waterboer T, Neale RE.

J Gen Virol. 2010 Jul;91(Pt 7):1849-53. doi: 10.1099/vir.0.020115-0. Epub 2010 Mar 10.

PMID:
20219899
13.
15.

Anti-JC virus (JCV) antibody prevalence in the JCV Epidemiology in MS (JEMS) trial.

Bozic C, Subramanyam M, Richman S, Plavina T, Zhang A, Ticho B.

Eur J Neurol. 2014 Feb;21(2):299-304. doi: 10.1111/ene.12304. Epub 2013 Nov 30.

PMID:
24894998
16.

BK and JC viruses in human immunodeficiency virus type 1-infected persons: prevalence, excretion, viremia, and viral regulatory regions.

Sundsfjord A, Flaegstad T, Flø R, Spein AR, Pedersen M, Permin H, Julsrud J, Traavik T.

J Infect Dis. 1994 Mar;169(3):485-90.

PMID:
8158020
18.

Prevalence rate and age of acquisition of antibodies against JC virus and BK virus in human sera.

Taguchi F, Kajioka J, Miyamura T.

Microbiol Immunol. 1982;26(11):1057-64.

20.

Bladder cancer and seroreactivity to BK, JC and Merkel cell polyomaviruses: the Spanish bladder cancer study.

Robles C, Viscidi R, Malats N, Silverman DT, Tardon A, Garcia-Closas R, Serra C, Carrato A, Herranz J, Lloreta J, Rothman N, Real FX, de Sanjose S, Kogevinas M.

Int J Cancer. 2013 Aug 1;133(3):597-603. doi: 10.1002/ijc.28053. Epub 2013 Feb 27.

Supplemental Content

Support Center